Cargando…
Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies
BACKGROUND: The prevalence of hepatitis C virus (HCV) infection in Egypt is the highest in the world, yet the total economic burden has not been quantified. Improved understanding of costs and the impact of treatment strategies will provide for better allocation of resources to reduce HCV disease an...
Autores principales: | Estes, C., Abdel‐Kareem, M., Abdel‐Razek, W., Abdel‐Sameea, E., Abuzeid, M., Gomaa, A., Osman, W., Razavi, H., Zaghla, H., Waked, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034818/ https://www.ncbi.nlm.nih.gov/pubmed/26202593 http://dx.doi.org/10.1111/apt.13316 |
Ejemplares similares
-
Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013) -
The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment
por: Kandeel, Amr, et al.
Publicado: (2016) -
Current hepatitis C infection /
Publicado: (2002) -
Estimation of COVID-19 burden in Egypt
por: Hassany, Mohamed, et al.
Publicado: (2020) -
HCV disease burden and population segments in Switzerland
por: Bihl, Florian, et al.
Publicado: (2021)